Source: Equity Guru

Stellarbiotechnologies: Stellar Biotechnologies (SBOT.Q) stock jumps 78% on news of successful acquisition

According to the World Health Organization, around 50 million people suffer from dementia worldwide and nearly 10 million new cases are diagnosed every year. Alzheimers disease is the most common form of dementia and may contribute to 60-70% of cases. This harrowing statistic is what makes a company like Stellar Biotechnologies (SBOT.Q), which is fighting [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
CEO Avatar

President & CEO

Frank Oakes

CEO Approval Rating

69/100

Read more